291 310

Cited 0 times in

A unique histone deacetylase inhibitor alters microRNA expression and signal transduction in chemoresistant ovarian cancer cells

Authors
 Curt Balch  ;  Kaleb Naegeli  ;  Seungyoon Nam  ;  Brett Ballard  ;  Alan Hyslop  ;  Christina Melki  ;  Elizabeth Reilly  ;  Man-Wook Hur  ;  Kenneth P. Nephew 
Citation
 CANCER BIOLOGY & THERAPY, Vol.13(8) : 681-693, 2012 
Journal Title
 CANCER BIOLOGY & THERAPY 
ISSN
 1538-4047 
Issue Date
2012
MeSH
Apoptosis/drug effects ; Cell Line, Tumor ; Cluster Analysis ; Drug Resistance, Neoplasm ; Female ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic/drug effects* ; Histone Deacetylase Inhibitors/pharmacology* ; Humans ; MicroRNAs/genetics* ; Molecular Sequence Annotation ; Ovarian Neoplasms/genetics* ; Ovarian Neoplasms/metabolism* ; Phenylbutyrates/pharmacology* ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Signal Transduction/drug effects* ; Wnt Proteins/metabolism
Keywords
epithelial-to-mesenchymal transition ; histone deacetylase inhibitor ; microRNA ; ovarian cancer ; Wnt signaling
Abstract
Previously, we demonstrated potent antineoplastic activity of a distinctive histone deacetylase inhibitor (HDACI), AR42, against chemoresistant CP70 ovarian cancer cells in vitro and in vivo. Here, in follow-up to that work, we explored AR42 global mechanisms-of-action by examining drug-associated, genome-wide microRNA and mRNA expression profiles, which differed from those of the well-studied HDACI vorinostat. Expression of microRNA genes in negative correlation with their "target" coding gene (mRNA) transcripts, and transcription factor genes with expression positively correlated with coding genes having their cognate binding sites, were identified and subjected to gene ontology analyses. Those evaluations showed AR42 gene expression patterns to negatively correlate with Wnt signaling (> 18-fold induction of SFRP1), the epithelial-to-mesenchymal transition (40% decreased ATF1), and cell cycle progression (33-fold increased 14-3-3σ). By contrast, AR42 transcriptome alterations correlated positively with extrinsic ("death receptor") apoptosis (> 2.3-fold upregulated DAPK) and favorable ovarian cancer histopathology and prognosis. Inhibition of Wnt signaling was experimentally validated by: (1) > 2.6-fold reduced Wnt reporter activity; and (2) 36% reduction in nuclear, activated β-catenin. Likely AR42 induction of multiple (type I or type II autophagic) cell death cascades was further supported by 57% decreased reliance upon reactive oxygen, increased mitochondrial membrane disruption, and caspase independence, as compared with vorinostat. Taken together, we demonstrate distinct antineoplastic pathway alterations, in aggressive ovarian cancer cells, following treatment with a promising HDACI, AR42. These combined computational and experimental approaches may also represent a straightforward means for mechanistic studies of other promising antineoplastics, and/or the identification of agents that may complement epigenetic therapies.
Files in This Item:
T201205836.pdf Download
DOI
22549158
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Biochemistry and Molecular Biology (생화학-분자생물학교실) > 1. Journal Papers
Yonsei Authors
Hur, Man Wook(허만욱) ORCID logo https://orcid.org/0000-0002-3416-1334
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/89860
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links